In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

While flu levels are still low, a strain that's wreaked havoc in the U.K. and Canada is behind most cases so far in the U.S., ...

The U.S. flu season is starting slowly, and it’s not clear if it will be as bad as last winter’s. But some health experts are ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...

Students on and near campus discussed their views on vaccines after BYU’s various vaccine clinics and initiatives.

Cell-based influenza vaccines were superior to egg-based vaccines across patient populations during a recent influenza season ...

Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.